HENRY NTORO: Open Payments
NPI 1740635283 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 24 payments from 10 companies in 2025. Trend: 2023 $751 · 2024 $376 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $299 |
| Otsuka America Pharmaceutical, Inc. | 7 | $217 |
| Vanda Pharmaceuticals Inc. | 3 | $89 |
| ABBVIE INC. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| CeQur Corporation | 1 | $15 |
Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, FARXIGA, THIRD WAVE, PREVNAR 20, ZENPEP.
Industry payments across MA — which companies pay providers there.
